We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+4.76%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$13.4B
AUM Growth
+$1.43B
Cap. Flow
+$857M
Cap. Flow %
6.4%
Top 10 Hldgs %
14.37%
Holding
602
New
156
Increased
172
Reduced
106
Closed
146

Top Buys

Rank Stock Value
1
TXN icon
Texas Instruments
TXN
+$175M
2
LOW icon
Lowe's Companies
LOW
+$167M
3
AZO icon
AutoZone
AZO
+$127M
4
NTRS icon
Northern Trust
NTRS
+$127M
5
MRK icon
Merck
MRK
+$118M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$133M
2
RAI
Reynolds American Inc
RAI
+$126M
3
KEY icon
KeyCorp
KEY
+$113M
4
WMT icon
Walmart Inc
WMT
+$110M
5
OA
Orbital ATK, Inc.
OA
+$108M

Sector Composition

Rank Sector Weight
1 Technology 16.72%
2 Industrials 14.06%
3 Consumer Discretionary 12.07%
4 Healthcare 11.22%
5 Financials 8.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APEI icon
276
American Public Education
APEI
$931M
$6.5M 0.05%
308,742
-20,102
-6% -$409K
DY icon
277
Dycom Industries
DY
$12B
$6.26M 0.05%
+72,943
New +$6.15M
FSTX
278
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$6.2M 0.05%
91,968
-7,502
-8% -$430K
CALX icon
279
Calix
CALX
$2.36B
$6.12M 0.05%
1,212,492
-150,328
-11% -$858K
BKD icon
280
Brookdale Senior Living
BKD
$3.43B
$6.09M 0.05%
574,115
-314,312
-35% -$3.98M
PETX
281
DELISTED
Aratana Therapeutics, Inc.
PETX
$5.91M 0.04%
964,116
+91,763
+11% +$581K
HUNT
282
DELISTED
Hunter Maritime Acquisition Corp. Common Stock
HUNT
$5.9M 0.04%
600,000
– –
CLDR
283
DELISTED
Cloudera, Inc.
CLDR
$5.73M 0.04%
+345,000
New +$6.14M
NBRV
284
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$5.72M 0.04%
+2,796
New +$6.56M
ASUR icon
285
Asure Software
ASUR
$252M
$5.59M 0.04%
450,000
+380,570
+548% +$4.72M
GDS icon
286
GDS Holdings
GDS
$6.38B
$5.57M 0.04%
494,844
+99,146
+25% +$966K
CNCE
287
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$5.43M 0.04%
368,243
+6,576
+2% +$95.4K
BKU icon
288
Bankunited
BKU
$3.37B
$5.34M 0.04%
+150,012
New +$5.04M
BSFT
289
DELISTED
BroadSoft, Inc.
BSFT
$5.19M 0.04%
103,209
-140,209
-58% -$6.4M
PLXS icon
290
Plexus
PLXS
$7.18B
$5.16M 0.04%
91,946
-88,933
-49% -$4.68M
UNIT
291
Uniti Group
UNIT
$2.33B
$5.13M 0.04%
+350,000
New +$7.39M
TWNK
292
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
$5.12M 0.04%
+375,000
New +$5.41M
CBIO
293
Crescent Biopharma
CBIO
$610M
$5.02M 0.04%
3,590
+90
+3% +$106K
ITW icon
294
Illinois Tool Works
ITW
$84.8B
$4.69M 0.04%
31,682
+4,906
+18% +$698K
SMPL icon
295
CALL
Simply Good Foods
SMPL
$988M
$4.68M 0.04%
+400,000
New +$4.74M
FFBC icon
296
First Financial Bancorp
FFBC
$3.55B
$4.62M 0.03%
+176,713
New +$4.52M
BA icon
297
Boeing
BA
$184B
$4.55M 0.03%
17,891
+9,255
+107% +$2.16M
CMBT
298
CMB.TECH NV
CMBT
$4.76B
$4.53M 0.03%
559,786
-547,421
-49% -$4.24M
DLB icon
299
Dolby
DLB
$5.71B
$4.53M 0.03%
+78,767
New +$4.13M
EVH icon
300
Evolent Health
EVH
$404M
$4.45M 0.03%
250,000
+199,300
+393% +$4.11M
10 11
12
13 14

Similar funds

Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
MML Investors Services
MML Investors Services Springfield, Massachusetts $36.1B AUM 19.68% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM

Alyeska Investment Group's Q3 2017 Portfolio in Review

As of Q3 2017, Alyeska Investment Group held 602 positions worth $13.4B, up 12% from $12B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Alyeska Investment Group deployed $857M of net new capital in Q3 2017, opening 156 new positions and adding to 172 existing holdings. Its largest new stake was AutoZone: 238,293 shares worth $142M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was AbbVie, an estimated $133M trimmed.

  • Alyeska Investment Group's largest Q3 2017 buy was AutoZone: 238,293 shares worth $142M.
  • Alyeska Investment Group added most to Texas Instruments in Q3 2017, an estimated $175M increase.
  • Alyeska Investment Group's biggest Q3 2017 reduction was AbbVie, cutting an estimated $133M.
  • Alyeska Investment Group fully exited Reynolds American Inc in Q3 2017, selling an estimated $126M.
  • Alyeska Investment Group's ten largest holdings make up 14% of its $13.4B portfolio in Q3 2017.
  • Alyeska Investment Group opened 156 new positions and closed 146 in Q3 2017.
  • Alyeska Investment Group's portfolio value rose 12% quarter-over-quarter to $13.4B.

Based on Alyeska Investment Group's 13F filing for Q3 2017, filed 14 Nov 2017.